BMS focuses on oncology, hematology, cardiovascular, and immunology therapies. The company is known for pioneering immuno-oncology treatments like Opdivo. In Canada, BMS maintains headquarters in Montreal with teams in regulatory affairs, medical affairs, market access, and sales. The Canadian operations are critical for clinical trials and providing access to innovative cancer treatments and specialty medicines. BMS Canada also engages extensively with patient organizations and health professionals.